Today, AMP made a number of trades in its hypothetical fund:
1.) Trimmed its Fibrogen (FGEN) and Uniqure (QURE) down to 10% of the portfolio. Both positions are big winners for AMP; FGEN is up over 200% while QURE's run in the last month has the position up over 100%.
2.) Increased its position in Clearside Biomedical (CLSD)
3.) Increased its position in Array Biopharma (ARRY)